Clinical Trial Detail

NCT ID NCT02236013
Title A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.

acute myeloid leukemia


Cytarabine + Idarubicin


Age Groups: adult

No variant requirements are available.